Protalix BioTherapeutics (PLX) EPS (Basic) (2010 - 2026)
Protalix BioTherapeutics (PLX) posted EPS (Basic) of $0.05 for Q2 2026, down 79.42% on a QoQ basis from $0.23 in Q1 2026, and up 2164.97% year-over-year from $0.0 in Q2 2025.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) EPS (Basic) (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics has reported EPS (Basic) for 17 years, with the latest figure at $0.05 in Q2 2026.
- On a quarterly basis, EPS (Basic) rose 2164.97% year-over-year to $0.05 in Q2 2026; TTM through Jun 2026 was $0.26, a 92.44% increase from a year earlier, with the FY2025 full-year figure at -$0.06, down 154.69% from the prior year.
- EPS (Basic) was $0.05 for Q2 2026 at Protalix BioTherapeutics, down from $0.23 in the prior quarter.
- The five-year high for EPS (Basic) was $0.24 in Q2 2023, with the low at -$0.11 in Q2 2022.
- Average EPS (Basic) over 5 years is $0.01, with a median of -$0.03 recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: EPS (Basic) plunged 127.85% in 2025, then surged 2164.97% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.07 in 2022, then soared by 122.75% to $0.02 in 2023, then jumped by 910.62% to $0.15 in 2024, then sank by 127.85% to -$0.04 in 2025, then surged by 211.38% to $0.05 in 2026.
- The last three EPS (Basic) figures came in at $0.05 (Q2 2026), $0.23 (Q1 2026), and -$0.04 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.12 Bn | 192.13 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.16 Bn | 176.98 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.95 Bn | 73.96 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.36 Bn | 55.18 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.01 Bn | 29.70 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.96 Bn | 30.67 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | -0.40 |
| 10 | Protalix BioTherapeutics | 217.16 Mn | 176.51 Mn | 12.13 Mn | 0.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | 0.15 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | -0.05 |
| Dec 31, 2022 | -0.07 |
| Sep 30, 2022 | -0.07 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.15 |
| Sep 30, 2021 | -0.09 |